Abstract
Although higher baseline International Prostate Symptom Score (IPSS) has been associated with increased toxicity after prostate brachytherapy, there are limited data specifically looking at the impact of IPSS on quality of life in men undergoing HDR. Our objective was to compare the patient-reported toxicity of men undergoing prostate HDR who had higher baseline IPSS vs. those with lower baseline IPSS
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
